Recombinant Toxins for Cancer Treatment
Data up to Jan 2025
Total Citations Per Year
Abstract
References (87)
Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes
1986 • 6,284 citations
Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas
1988 • 1,698 citations
Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli.
1988 • 1,536 citations
Single-Chain Antigen-Binding Proteins
1988 • 1,450 citations
Assembly of a Functional Immunoglobulin F v Fragment in Escherichia coli
1988 • 973 citations
Diphtheria Toxin
1977 • 780 citations
One molecule of diphtheria toxin fragment a introduced into a cell can kill the cell
1978 • 744 citations
B4, a human B lymphocyte-associated antigen expressed on normal, mitogen-activated, and malignant B lymphocytes.
1983 • 517 citations
Structure of exotoxin A of Pseudomonas aeruginosa at 3.0-Angstrom resolution.
1986 • 517 citations
Functional domains of pseudomonas exotoxin identified by deletion analysis of the gene expressed in E. coli
1987 • 449 citations
Epidermal-Growth-Factor-Dependent Transformation by a Human EGF Receptor Proto-Oncogene
1987 • 448 citations
A recombinant immunotoxin consisting of two antibody variable domains fused to Pseudomonas exotoxin
1989 • 420 citations
Human squamous cell lung cancers express increased epidermal growth factor receptors.
1984 • 371 citations
Redesigning Nature's Poisons to Create Anti-Tumor Reagents
1987 • 329 citations
Phase I immunotoxin trial in patients with B-cell lymphoma.
1991 • 289 citations
Immunotoxins: hybrid molecules of monoclonal antibodies and a toxin subunit specifically kill tumour cells
1981 • 253 citations
Diphtheria toxin receptor binding domain substitution with interleukin-2: genetic construction and properties of a diphtheria toxin-related interleukin-2 fusion protein
1987 • 236 citations
Processing of Pseudomonas exotoxin by a cellular protease results in the generation of a 37,000-Da toxin fragment that is translocated to the cytosol
1990 • 233 citations
Immunotoxins
1986 • 230 citations
B3(Fv)-PE38KDEL, a single-chain immunotoxin that causes complete regression of a human carcinoma in mice.
1991 • 219 citations
Receptor-mediated endocytosis of epidermal growth factor by rat hepatocytes: receptor pathway.
1986 • 217 citations
Therapy of patients with malignant melanoma using a monoclonal antimelanoma antibody-ricin A chain immunotoxin.
1987 • 212 citations
Functional Analysis of Domains II, Ib, and III of Pseudomonas exotoxin
1989 • 193 citations
Definition by monoclonal antibodies of a repertoire of epitopes on carcinoembryonic antigen differentially expressed in human colon carcinomas versus normal adult tissues.
1985 • 177 citations
Receptor-mediated internalization of pseudomonas toxin by mouse fibroblasts
1980 • 176 citations
Mutations in Diphtheria Toxin Separate Binding from Entry and Amplify Immunotoxin Selectivity
1987 • 173 citations
Targeted Toxin Therapy for the Treatment of Cancer
1989 • 158 citations
A rapid method of cloning functional variable-region antibody genes in Escherichia coli as single-chain immunotoxins.
1990 • 156 citations
Activity of immunotoxins constructed with modified Pseudomonas exotoxin A lacking the cell recognition domain.
1988 • 147 citations
Antigens associated with a human lung adenocarcinoma defined by monoclonal antibodies.
1984 • 142 citations
Characterization of monoclonal antibodies B1 and B3 that react with mucinous adenocarcinomas.
1991 • 140 citations
Cytotoxic activity of an interleukin 2-Pseudomonas exotoxin chimeric protein produced in Escherichia coli.
1988 • 133 citations
Pseudomonas exotoxin: chimeric toxins
1989 • 129 citations
Phase I Study of an Anti-Breast Cancer Immunotoxin by Continuous Infusion: Report of a Targeted Toxic Effect Not Predicted by Animal Studies
1989 • 124 citations
Clinical evaluation of intraperitoneal Pseudomonas exotoxin immunoconjugate OVB3-PE in patients with ovarian cancer.
1991 • 124 citations
Phase I evaluation of an anti-breast carcinoma monoclonal antibody 260F9-recombinant ricin A chain immunoconjugate.
1989 • 122 citations
In vivo therapy of a murine B cell tumor (BCL1) using antibody-ricin A chain immunotoxins.
1982 • 122 citations
How protein toxins enter and kill cells
1988 • 122 citations
Evaluation of ricin A chain-containing immunotoxins directed against CD19 and CD22 antigens on normal and malignant human B-cells as potential reagents for in vivo therapy.
1988 • 116 citations
TRANSMEMBRANE TRANSPORT OF DIPHTHERIA TOXIN, RELATED TOXINS, AND COLICINS
1986 • 115 citations
Ricin A-chain containing immunotoxins directed against different epitopes on the CD2 molecule differ in their ability to kill normal and malignant T cells.
1988 • 95 citations
Blockade of the galactose‐binding sites of ricin by its linkage to antibody
1984 • 93 citations
Pseudomonas exotoxin-anti-TAC. Cell-specific immunotoxin active against cells expressing the human T cell growth factor receptor.
1984 • 92 citations
Expression of soluble and fully functional ricin A chain in Escherichia coli is temperature-sensitive.
1988 • 92 citations
Tissue distribution of breast cancer-associated antigens defined by monoclonal antibodies.
1985 • 88 citations
Phase I study of monoclonal antibody-ricin A chain immunotoxin XomaZyme-791 in patients with metastatic colon cancer.
1989 • 88 citations
Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4- hydroperoxycyclophosphamide for marrow purging
1990 • 88 citations
Mutational analysis of domain I of Pseudomonas exotoxin. Mutations in domain I of Pseudomonas exotoxin which reduce cell binding and animal toxicity.
1988 • 87 citations
The galactose-binding sites of the cytotoxic lectin ricin can be chemically blocked in high yield with reactive ligands prepared by chemical modification of glycopeptides containing triantennary N-linked oligosaccharides
1991 • 85 citations
Cytotoxic activity of an interleukin 6-Pseudomonas exotoxin fusion protein on human myeloma cells.
1988 • 82 citations
Single-chain immunotoxins directed at the human transferrin receptor containing Pseudomonas exotoxin A or diphtheria toxin: anti-TFR(Fv)-PE40 and DT388-anti-TFR(Fv).
1991 • 81 citations
Cellular processing of the interleukin-2 fusion toxin DAB486-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194
1990 • 81 citations
A recombinant single-chain immunotoxin composed of anti-Tac variable regions and a truncated diphtheria toxin.
1990 • 80 citations
Autologous bone marrow transplantation in high-risk remission T-lineage acute lymphoblastic leukemia using immunotoxins plus 4- hydroperoxycyclophosphamide for marrow purging
1990 • 80 citations
The recombinant immunotoxin anti-Tac(Fv)-Pseudomonas exotoxin 40 is cytotoxic toward peripheral blood malignant cells from patients with adult T-cell leukemia.
1990 • 80 citations
Antitumor activity in mice of an immunotoxin made with anti-transferrin receptor and a recombinant form of Pseudomonas exotoxin.
1989 • 76 citations
Cloned fragment of diphtheria toxin linked to T cell-specific antibody identifies regions of B chain active in cell entry.
1986 • 76 citations
Anti-tumor activities of immunotoxins made of monoclonal antibody B3 and various forms of Pseudomonas exotoxin.
1991 • 70 citations
Transforming growth factor alpha-Pseudomonas exotoxin fusion protein prolongs survival of nude mice bearing tumor xenografts.
1990 • 69 citations
A phase I study of T101-ricin A chain immunotoxin in refractory chronic lymphocytic leukemia.
1988 • 69 citations
Antitumor activity of intraperitoneal immunotoxins in a nude mouse model of human malignant mesothelioma.
1987 • 67 citations
Antitumor activity of a transforming growth factor alpha-Pseudomonas exotoxin fusion protein (TGF-alpha-PE40).
1991 • 66 citations
Pseudomonas exotoxin coupled to a monoclonal antibody against ovarian cancer inhibits the growth of human ovarian cancer cells in a mouse model.
1987 • 64 citations
Epidermal growth factor receptor expression in 72 meningiomas
1990 • 63 citations
Epidermal Growth Factor in the Normal and Neoplastic Kidney and Bladder
1988 • 60 citations
Antitumor activity of an immunotoxin in a nude mouse model of human ovarian cancer.
1987 • 60 citations
Cytotoxicity of interleukin 2-toxin toward lymphocytes from patients with adult T-cell leukemia.
1989 • 56 citations
Cytotoxicity of a recombinant ricin‐A‐chain fusion protein containing a proteolytically‐cleavable spacer sequence
1990 • 54 citations
Cytotoxicity against human tumor cells mediated by the conjugate of anti-epidermal growth factor receptor monoclonal antibody to recombinant ricin A chain.
1989 • 54 citations
In vitro endoproteolytic cleavage of castor bean lectin presursors
1985 • 49 citations
Sequential effects of interleukin 2-diphtheria toxin fusion protein on T-cell activation.
1989 • 49 citations
Oncogene‐associated tumor antigens as targets for immunotherapy
1989 • 48 citations
Cytotoxic activity of a recombinant fusion protein between interleukin 4 and Pseudomonas exotoxin.
1989 • 42 citations
Antitumor effects of interleukin 6-Pseudomonas exotoxin chimeric molecules against the human hepatocellular carcinoma, PLC/PRF/5 in mice.
1991 • 36 citations
Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.
1989 • 35 citations
Cytotoxic activity of chimeric proteins composed of acidic fibroblast growth factor and Pseudomonas exotoxin on a variety of cell types
1991 • 31 citations
Isolation and characterization of Pseudomonas aeruginosa exotoxin A binding glycoprotein from mouse LM cells
1991 • 30 citations
Cytotoxic activity of a recombinant fusion protein between insulin-like growth factor I and Pseudomonas exotoxin.
1991 • 29 citations
Intracellular routing rather than cross-linking or rate of internalization determines the potency of immunotoxins directed against different epitopes of sIgD on murine B cells
1991 • 27 citations
Diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion toxin. Internal in-frame deletion from Thr387 to His485 results in the formation of a highly potent fusion toxin which is resistant to proteolytic degradation
1991 • 25 citations
Cytotoxicity of IL6-PE40 and derivatives on tumor cells expressing a range of interleukin 6 receptor levels.
1990 • 25 citations
IL-2-PE40 prevents the development of tumors in mice injected with IL-2 receptor expressing EL4 transfectant tumor cells.
1990 • 25 citations
IL-2-PE40 is cytotoxic for activated T lymphocytes expressing IL-2 receptors.
1988 • 24 citations
Diphtheria-related peptide hormone gene fusions: A molecular genetic approach to chimeric toxin development
1988 • 20 citations
Pseudomonas exotoxin — Immunotoxins
1988 • 20 citations
The interleukin-2 receptor on malignant cells: A target for diagnosis and therapy
1986 • 17 citations
Treatment of leukemia patients with T101 ricin A chain immunotoxins
1988 • 13 citations